India to Ban Cipro Floxacine and Ciprolipid Dairy Products for 1st Time
India’s government on Friday announced that it will ban the use of the drug Cipropin for the first time, following reports that it had been used to treat a massive outbreak of coronavirus.
The government said in a statement that the move was “in the interest of public health and the safety of the people.”
It said the drug, which was first approved in India in 2008, was “being used illegally.”
India’s largest milk producer, the Union of India, has said that its milk and other dairy products could be affected by the ban, but has not yet provided any details on what products will be affected.
The World Health Organization has said the disease has killed more than 9,600 people and that it has killed at least 1,000 people in India, Pakistan, Bangladesh and Nepal.
Cipropine was developed by Pfizer and has been approved by the U.S. Food and Drug Administration (FDA) for treating severe diarrhea, diarrhea-associated urinary tract infections, pneumonia, and stomach disorders.
The drug has also been used in the treatment of other respiratory conditions.
India’s government is still reviewing the drug and will decide whether to take further action on it, said the statement from the Ministry of Health and Family Welfare.
India banned the use in 2011 of Cipramox, a drug used to control fever and cough.
The government said then that the drug had been approved only in China.
China has approved Cipranil for use in China but India has not.
India has also had to deal with a huge outbreak of the coronaviruses coronaviral and influenza A (H1N1).
India’s largest dairy producer, Panchshil, has announced that its products will not be sold after the ban takes effect.
Panchshils head, Pravin Tandon, said that Panchshera Dairy Products will sell its dairy products in the country only after the government gives its consent.